Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for TerrAscend Corp. (TSNDF : OTC)

• Company Description    TerrAscend is a cannabis operator with vertically integrated operations principally in Pennsylvania, New Jersey and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. TerrAscend is based in NEW YORK. Number of Employees: 1,038

• Price / Volume Information    Yesterday's Closing Price: $0.67 Daily Weekly Monthly 20 Day Moving Average: 650,767 shares Shares Outstanding: 308.42 (millions) Market Capitalization: $207.69 (millions) Beta: 1.42 52 Week High: $1.45 52 Week Low: $0.23 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.74% -4.50% 12 Week -9.54% -17.25% Year To Date -6.47% -14.65%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 77 City Centre Drive Suite 501 - East Tower - Mississauga,A6 L5B 1M5 CAN ph: 844-628-3100 fax: - ir@terrascend.com http://www.terrascend.com

• General Corporate Information    Officers Ziad Ghanem - President and Chief Executive Officer Jason Wild - Director Ira Duarte - Director Craig Collard - Director Ed Schutter - Director Peer Information TerrAscend Corp. (BJCT) TerrAscend Corp. (CADMQ) TerrAscend Corp. (APNO) TerrAscend Corp. (UPDC) TerrAscend Corp. (IMTIQ) TerrAscend Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 88105E108 SIC: 100 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 308.42 Most Recent Split Date: (:1) Beta: 1.42 Market Capitalization: $207.69 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.08 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.28 Price/Cash Flow: - Price / Sales: 0.79 EPS Growth vs. Year Ago Period: 40.00% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -7.69% vs. Previous Quarter: -0.92% ROE 03/31/26 - -24.69 12/31/25 - -26.50 09/30/25 - -18.32 ROA 03/31/26 - -4.46 12/31/25 - -5.54 09/30/25 - -4.36 Current Ratio 03/31/26 - 1.51 12/31/25 - 1.38 09/30/25 - 1.56 Quick Ratio 03/31/26 - 0.98 12/31/25 - 0.95 09/30/25 - 1.12 Operating Margin 03/31/26 - -9.52 12/31/25 - -11.85 09/30/25 - -9.24 Net Margin 03/31/26 - -44.87 12/31/25 - -46.04 09/30/25 - -42.72 Pre-Tax Margin 03/31/26 - 2.15 12/31/25 - 1.94 09/30/25 - 5.06 Book Value 03/31/26 - 0.29 12/31/25 - 0.32 09/30/25 - 0.31 Inventory Turnover 03/31/26 - 3.60 12/31/25 - 3.31 09/30/25 - 3.00 Debt-to-Equity 03/31/26 - 2.66 12/31/25 - 2.42 09/30/25 - 2.54 Debt-to-Capital 03/31/26 - 72.65 12/31/25 - 70.73 09/30/25 - 71.75

Powered by Zacks Investment Research ©